Fortis Healthcare Ltd
Fortis Healthcare Ltd (FORTIS) last reported results for the quarter ended Jun 2026, with sales of ₹2,545 crore and net profit of ₹273 crore. The stock last traded at ₹767, a market capitalisation of ₹57,894 crore, on a P/E of 54.3. Over the past 52 weeks the stock has ranged between ₹745 and ₹1,105. Figures are as of 6 Oct 2026 and are not real time.
Fortis Healthcare Ltd share price and key metrics
- Current price
- ₹767
- Market cap
- ₹57,894 cr
- Stock P/E
- 54.3
- Book value
- ₹131
- ROE
- 11.2%
- ROCE
- 13.4%
- Dividend yield
- 0.13%
- 52w high / low
- 1105/745
Metrics as of 6 Oct 2026. Not real time.
Track Fortis Healthcare Ltd
Cruxal reads every Fortis Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Fortis Healthcare Ltd growth and returns
- 10 Years
- 8%
- 5 Years
- 18%
- 3 Years
- 13%
- TTM
- 18%
- 10 Years
- 60%
- 5 Years
- 64%
- 3 Years
- 27%
- TTM
- 16%
- 10 Years
- 16%
- 5 Years
- 23%
- 3 Years
- 33%
- 1 Year
- -28%
- 10 Years
- 5%
- 5 Years
- 9%
- 3 Years
- 10%
- Last Year
- 11%
Fortis Healthcare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹2,545 cr, up 17.4% from ₹2,167 cr a year earlier. Net profit was ₹273 cr, up 2.2% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,988 | 1,928 | 2,007 | 2,167 | 2,331 | 2,265 | 2,365 | 2,545 |
| Expenses | 1,554 | 1,553 | 1,572 | 1,676 | 1,775 | 1,759 | 1,832 | 2,008 |
| Operating profit | 435 | 375 | 435 | 491 | 556 | 506 | 532 | 537 |
| OPM % | 22% | 19% | 22% | 23% | 24% | 22% | 23% | 21% |
| Other income | -42 | 47 | -29 | 31 | 50 | -34 | -2 | 28 |
| Interest | 36 | 45 | 68 | 70 | 75 | 86 | 84 | 80 |
| Depreciation | 95 | 97 | 102 | 101 | 106 | 120 | 122 | 122 |
| Profit before tax | 261 | 279 | 237 | 351 | 425 | 266 | 324 | 363 |
| Tax % | 26% | 9% | 21% | 24% | 23% | 26% | 16% | 25% |
| Net profit | 193 | 254 | 188 | 267 | 329 | 197 | 271 | 273 |
| EPS (₹) | 2.34 | 3.28 | 2.44 | 3.45 | 4.26 | 2.57 | 3.52 | 3.53 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Fortis Healthcare Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,574 | 4,561 | 4,469 | 4,632 | 4,030 | 5,718 | 6,298 | 6,893 | 7,783 | 9,128 | 9,506 |
| Operating profit | 354 | 274 | 231 | 610 | 404 | 1,069 | 1,101 | 1,268 | 1,588 | 2,085 | 2,131 |
| OPM % | 8% | 6% | 5% | 13% | 10% | 19% | 17% | 18% | 20% | 23% | 22% |
| Net profit | 479 | -934 | -224 | 91 | -56 | 790 | 633 | 645 | 809 | 1,064 | 1,070 |
| EPS (₹) | 8.14 | -19.46 | -3.96 | 0.77 | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 | 13.80 | 13.88 |
TTM is the trailing twelve months to the most recent quarter.
Fortis Healthcare Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 518 | 519 | 755 | 755 | 755 | 755 | 755 | 755 | 755 | 755 |
| Reserves | 4,626 | 3,543 | 5,846 | 5,906 | 5,365 | 5,423 | 6,487 | 6,908 | 8,162 | 9,141 |
| Borrowings | 2,217 | 1,962 | 2,010 | 1,594 | 1,531 | 1,255 | 926 | 1,155 | 2,475 | 3,473 |
| Other liabilities | 2,227 | 2,455 | 2,875 | 2,781 | 3,216 | 4,082 | 3,921 | 4,153 | 1,985 | 2,465 |
| Total liabilities | 9,588 | 8,479 | 11,486 | 11,036 | 10,866 | 11,516 | 12,089 | 12,971 | 13,377 | 15,833 |
| Fixed assets | 5,419 | 4,992 | 8,477 | 8,802 | 8,799 | 9,416 | 9,426 | 9,874 | 10,424 | 12,230 |
| CWIP | 268 | 226 | 450 | 204 | 165 | 193 | 228 | 542 | 407 | 434 |
| Investments | 1,878 | 1,732 | 270 | 175 | 186 | 104 | 210 | 230 | 169 | 243 |
| Other assets | 2,023 | 1,529 | 2,290 | 1,856 | 1,716 | 1,803 | 2,225 | 2,326 | 2,378 | 2,926 |
| Total assets | 9,588 | 8,479 | 11,486 | 11,036 | 10,866 | 11,516 | 12,089 | 12,971 | 13,377 | 15,833 |
As reported by the company. Total assets equal total liabilities by construction.
Fortis Healthcare Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 966 | 493 | -179 | 172 | 485 | 865 | 822 | 1,100 | 1,424 | 1,601 |
| Cash from investing | -1,001 | -333 | -3,279 | 63 | -131 | -501 | -372 | -889 | -780 | -1,537 |
| Cash from financing | 259 | -672 | 4,257 | -862 | -143 | -517 | -471 | -86 | -714 | 164 |
| Net cash flow | 225 | -513 | 799 | -627 | 212 | -153 | -21 | 125 | -70 | 228 |
| Free cash flow | 689 | 437 | -261 | 35 | 274 | 750 | 367 | 172 | 591 | 673 |
| CFO / operating profit | 304% | 187% | 30% | 84% | 108% | 101% | 100% | 104% | 97% | 90% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Fortis Healthcare Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 11% | 3% | 6% | 4% | 2% | 10% | 10% | 10% | 12% | 13% |
| Debtor days | 38 | 38 | 44 | 36 | 41 | 33 | 34 | 33 | 37 | 42 |
| Inventory days | 23 | 24 | 22 | 30 | 29 | 33 | 31 | 24 | 23 | 24 |
| Days payable | 215 | 279 | 296 | 226 | 205 | 178 | 179 | 164 | 161 | 165 |
| Cash conversion cycle | -155 | -217 | -230 | -161 | -135 | -112 | -115 | -107 | -101 | -99 |
| Working capital days | -87 | -113 | -234 | -150 | -56 | -35 | -22 | -124 | -30 | -34 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Fortis Healthcare Ltd shareholding pattern
Promoters held 31.17% at Jun 2026, broadly unchanged since Jun 2025. FIIs 25.20% and DIIs 32.23%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% |
| FIIs | 25.26% | 26.77% | 27.40% | 27.18% | 27.90% | 27.84% | 25.98% | 25.20% |
| DIIs | 30.73% | 30.05% | 29.46% | 29.79% | 29.14% | 29.33% | 31.35% | 32.23% |
| Public | 12.83% | 12.02% | 11.98% | 11.87% | 11.79% | 11.65% | 11.50% | 11.40% |
| No. of shareholders | 2,04,184 | 2,21,750 | 2,18,329 | 2,05,373 | 2,20,766 | 2,33,156 | 2,26,685 | 2,20,743 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Fortis Healthcare Ltd corporate filings
- The relevant disclosure is attached.Company Updatelow impact
- Fortis Healthcare provides update on Special Leave Petition (SLP) before Supreme CourtCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has filed a disclosure regarding the status of a Special Leave Petition…
Read the full analysis - The relevant disclosureis attached.Insider Trading / SASTlow impact
- Fortis Healthcare provides update on ongoing litigation with Northern TK Venture Pte Ltd in Tokyo District CourtCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has issued a routine disclosure regarding the status of material…
Read the full analysis - Fortis Healthcare Ltd files routine regulatory disclosure under Regulation 30Company Updatelow impact
Cruxal's analysis: Fortis Healthcare Ltd has submitted a routine disclosure under Regulation 30 of the SEBI…
Read the full analysis - Fortis Healthcare subsidiary signs agreement for 400+ bedded hospital in Ashok Vihar, New DelhiCompany Updatemedium impact
Cruxal's analysis: Fortis Hospotel Limited, a wholly owned subsidiary of Fortis Healthcare, has signed…
Read the full analysis - Fortis Healthcare files Special Leave Petition (SLP) before the Supreme Court of IndiaCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has submitted a Special Leave Petition (SLP) to the Supreme Court of…
Read the full analysis - Fortis Healthcare Ltd announces intimation of analyst/investor meetCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has filed a routine intimation regarding an upcoming analyst/investor…
Read the full analysis - Fortis Healthcare Ltd announces intimation of analyst/investor meetCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has issued a formal intimation regarding an upcoming analyst/investor…
Read the full analysis - Fortis Healthcare provides update on ongoing litigation with Daiichi Sankyo in Tokyo District CourtCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has issued a disclosure regarding material litigation filed by its…
Read the full analysis - Fortis Healthcare clarifies Delhi High Court forensic audit order; management maintains operations and growth plans remain unaffectedCompany Updatemedium impact
Cruxal's analysis: Fortis Healthcare Limited held an investor conference call to address a recent Delhi High…
Read the full analysis - Fortis Healthcare Ltd issues revised intimation for analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has filed a revised intimation regarding an upcoming analyst or…
Read the full analysis - Fortis Healthcare Ltd issues revised intimation for analyst/investor meetCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has released a revised intimation regarding an upcoming…
Read the full analysis - Fortis Healthcare Ltd schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has issued a routine intimation regarding an upcoming analyst/investor…
Read the full analysis - Fortis Healthcare Ltd announces intimation of analyst/investor meetCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has filed a routine intimation regarding an upcoming analyst or…
Read the full analysis - Fortis Healthcare Ltd schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has issued a routine intimation regarding an upcoming analyst/investor…
Read the full analysis - Fortis Healthcare reports Delhi High Court order for forensic audit into historical shareholding changesCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare Limited has disclosed that the Delhi High Court has ordered a forensic…
Read the full analysis - Fortis Healthcare Ltd discloses ESG rating updateCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare has submitted a disclosure regarding its ESG rating. The filing is a…
Read the full analysis - Fortis Healthcare Q1 FY27 Earnings Call: Revenue Growth of 17.5% YoY, Margin Guidance Maintained at 25% Despite ESOP ImpactCompany Updatehigh impact
Cruxal's analysis: Fortis Healthcare reported consolidated revenue of INR 2,545 crore for Q1 FY27, a 17.5%…
Read the full analysis - Fortis Healthcare Limited Announces Voting Results of 30th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Fortis Healthcare Limited has successfully concluded its 30th Annual General Meeting held…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.